Lenalidomide (LENA) Hybrid Gold Complex Nanoparticles: Synthesis, Physicochemical Evaluation, and Perspectives in Nanomedicine-Reference-Cited by-同舟云学术

Lenalidomide (LENA) Hybrid Gold Complex Nanoparticles: Synthesis, Physicochemical Evaluation, and Perspectives in Nanomedicine

Published:2020-10-30 Issue:44 Volume:5 Page:28483-28492
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Arib Celia¹,Spadavecchia Jolanda¹^ORCID

Affiliation:

1. CNRS, UMR 7244, NBD-CSPBAT, Laboratory of Chemistry, Structures and Properties of Biomaterials and Therapeutic Agents University Paris 13, Sorbonne Paris Nord, 93000 Bobigny, France

Funder

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.acs.org/doi/pdf/10.1021/acsomega.0c02644

Reference48 articles.

1. Cancer nanomedicine: progress, challenges and opportunities

2. Nanoparticle-Mediated Combination Therapy: Two-in-One Approach for Cancer

3. Pharmaceutical clinical services in basic care in a region of the municipality of São Paulo

4. Thalidomide-analogue biology: immunological, molecular and epigenetic targets in cancer therapy

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Al/ZnO nanoparticle as an effective nanocarrier in delivery of lenalidomide anti-multiple myeloma cancer drug;Materials Technology;2024-04-02

2. Lenalidomide Promotes Melarsoprol-Activated cGAS-STING-Mediated Immunotherapy for Hepatocellular Carcinoma via Attenuating TNF-α Activity;Fundamental Research;2023-06

3. Experimental analysis and thermodynamic modelling of lenalidomide solubility in supercritical carbon dioxide;Arabian Journal of Chemistry;2022-06

4. Targeted Drug Delivery for Chronic Lymphocytic Leukemia;Pharmaceutical Research;2022-03

5. β-cyclodextrin-lenalidomide anticancer drug delivery nanosystem: A quantum chemical approach;Journal of Molecular Liquids;2021-12